NAACCR Item #3921: Residual Tumor Volume Post Cytoreduction

Start Column

1920

End Column

1921

Alignment

LEFT

Padding Character

' '

Documentation

Item # Length Source of Standard Year Implemented Version Implemented Year Retired Version Retired Column #
3921 2 NAACCR 2018 18 1920 - 1921

NAACCR XML: Tumor.residualTumVolPostCytoreduction

Description
Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers.
Rationale
Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3.
Codes
00 No gross residual tumor nodules
10 Residual tumor nodule(s) 1 centimeter (cm) or less
AND neoadjuvant chemotherapy not given or unknown if given
20 Residual tumor nodule(s) 1 cm or less
AND neoadjuvant chemotherapy given (before surgery)
30 Residual tumor nodule(s) greater than 1 cm
AND neoadjuvant chemotherapy not given or unknown if given
40 Residual tumor nodule(s) greater than 1 cm
AND neoadjuvant chemotherapy given (before surgery)
90 Macroscopic residual tumor, size not stated
AND neoadjuvant chemotherapy not given or unknown if given
91 Macroscopic residual tumor nodule(s), size not stated
AND neoadjuvant chemotherapy given (before surgery)
92 Procedure described as optimal debulking and size of residual tumor nodule(s) not given
AND neoadjuvant chemotherapy not given or unknown if given
93 Procedure described as optimal debulking and size of residual tumor nodule(s) not given
AND neoadjuvant chemotherapy given (before surgery)
97 No cytoreductive surgery performed
98 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 98 will result in an edit error.)
99 Not documented in medical record
Residual tumor status after cytoreductive surgery not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.